Addition requirement for certain pharmaceutical marketing expenses

Summary

The bill requires that expenses a company deducts for consumer‑focused drug advertising be added back to its Minnesota taxable income. It applies to both corporate franchise and individual income taxes and takes effect for tax years starting after Dec. 31, 2026. The change aims to reduce the tax benefit of such marketing spending.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share